Ghosh HS, Patel R V, Woodward E, et al. Contemporary Prognostic Signatures and Refined Risk Stratification of Gliomas: An Analysis of 4,400 Tumors. Neuro-oncology. 2024. doi:10.1093/neuonc/noae164.

Ghosh HS, Patel R V, Woodward E, et al. Contemporary Prognostic Signatures and Refined Risk Stratification of Gliomas: An Analysis of 4,400 Tumors. Neuro-oncology. 2024. doi:10.1093/neuonc/noae164.

Williams EA, Brastianos PK, Wakimoto H, et al. A comprehensive genomic study of 390 H3F3A-mutant pediatric and adult diffuse high-grade gliomas, CNS WHO grade 4. Acta neuropathologica. 2023. doi:10.1007/s00401-023-02609-6.

Huillard E, Hashizume R, Phillips JJ, et al. Cooperative interactions of BRAFV600E kinase and CDKN2A locus deficiency in pediatric malignant astrocytoma as a basis for rational therapy. Proc Natl Acad Sci U S A. 2012;109(22):8710-5. doi:10.1073/pnas.1117255109.

Suvà ML. Genetics and epigenetics of gliomas. Swiss Med Wkly. 2014;144:w14018. doi:10.4414/smw.2014.14018.

Shankar GM, Lelic N, Gill CM, et al. BRAF alteration status and the histone H3F3A gene K27M mutation segregate spinal cord astrocytoma histology. Acta Neuropathol. 2016;131(1):147-50. doi:10.1007/s00401-015-1492-2.